Role of Neuromuscular Junction Function in Motor Fatigue in Multiple Sclerosis
| Status: | Recruiting |
|---|---|
| Conditions: | Neurology, Neurology, Multiple Sclerosis |
| Therapuetic Areas: | Neurology, Other |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 5/5/2016 |
| Start Date: | April 2015 |
| End Date: | December 2016 |
| Contact: | Ahmed M Eldokla, MD |
| Email: | ahmed.eldokla@ttuhsc.edu |
| Phone: | 806 743 2391 |
Does Abnormal Neuromuscular Junction Function Play a Role in the Pathogenesis of Motor Fatigue in Women With Multiple Sclerosis?
This pilot study will evaluate for the presence of neuromuscular junction (NMJ) defect in
women with motor fatigue in multiple sclerosis by Single Fiber Electromyography (SFEMG)
using the concentric needle electrode.
women with motor fatigue in multiple sclerosis by Single Fiber Electromyography (SFEMG)
using the concentric needle electrode.
The investigators will recruit 20 women with multiple sclerosis (MS) and fatigue and 10
normal controls with no identified causes of fatigue (no history of thyroid disease, anemia,
liver disease, kidney disease, myasthenia gravis, and no major fatigue inducing
medications). We will include MS patients with fatigue severity scale of ≥5. Patients with
sleep disorders or significant depression will be excluded based on history, Epworth
Sleepiness scale, and Beck's Inventory of Depression Scale. The study will include two
clinic visits and a one-study visit. After informed consent is obtained (English and Spanish
forms will be available), the following will be done during the study visit 1:
- Neurological examination: Using handgrip dynamometer of the dominant hand.
- Maximum voluntary isometric contraction force (MVIC) of the handgrip; two
contractions of as long as 5 seconds each.
- Single 30 seconds sustained maximal contraction of the handgrip to assess static
fatigue.
- Series of brief maximal contraction over 30 seconds, Contractions will be timed at
one contraction per second.
- Expanded Disability Status Scale (EDSS
- Fatigue severity scale (FSS) and modified fatigue impact scale (MFIS)
- Epworth Sleepiness scale for screening for sleep disorders.
- Beck's Inventory of Depression Scale for screening for depression. Clinic visit 2: The
clinic visit 2 will be conducted 5-30 days after the clinic visit 1
- Neurological examination: Using handgrip dynamometer of the dominant hand.
- Maximum voluntary isometric contraction force (MVIC) of the handgrip; two
contractions of as long as 5 seconds each.
- Single 30 seconds sustained maximal contraction of the handgrip to assess static
fatigue.
- Series of brief maximal contraction over 30 seconds, Contractions will be timed at
one per second.
- Fatigue severity scale (FSS) and modified fatigue impact scale (MFIS)
Study Visit 3:
Electromyography (EMG) and SFEMG (Single Fiber Electromyography) of the extensor digitorum
communis muscle (forearm muscle) will be performed on all women with fatigue and healthy
controls at the TTUHSC electrophysiology lab to evaluate for NMJ abnormalities. The mean
consecutive difference (MCD) of 20 pairs of single muscle fiber potentials will be collected
using SFEMG from each of the 20 women with multiple sclerosis and fatigue and will be
compared to MCD of 200 pair potentials from our recruited 10 normal control subjects and
also to the previously published normative data.
normal controls with no identified causes of fatigue (no history of thyroid disease, anemia,
liver disease, kidney disease, myasthenia gravis, and no major fatigue inducing
medications). We will include MS patients with fatigue severity scale of ≥5. Patients with
sleep disorders or significant depression will be excluded based on history, Epworth
Sleepiness scale, and Beck's Inventory of Depression Scale. The study will include two
clinic visits and a one-study visit. After informed consent is obtained (English and Spanish
forms will be available), the following will be done during the study visit 1:
- Neurological examination: Using handgrip dynamometer of the dominant hand.
- Maximum voluntary isometric contraction force (MVIC) of the handgrip; two
contractions of as long as 5 seconds each.
- Single 30 seconds sustained maximal contraction of the handgrip to assess static
fatigue.
- Series of brief maximal contraction over 30 seconds, Contractions will be timed at
one contraction per second.
- Expanded Disability Status Scale (EDSS
- Fatigue severity scale (FSS) and modified fatigue impact scale (MFIS)
- Epworth Sleepiness scale for screening for sleep disorders.
- Beck's Inventory of Depression Scale for screening for depression. Clinic visit 2: The
clinic visit 2 will be conducted 5-30 days after the clinic visit 1
- Neurological examination: Using handgrip dynamometer of the dominant hand.
- Maximum voluntary isometric contraction force (MVIC) of the handgrip; two
contractions of as long as 5 seconds each.
- Single 30 seconds sustained maximal contraction of the handgrip to assess static
fatigue.
- Series of brief maximal contraction over 30 seconds, Contractions will be timed at
one per second.
- Fatigue severity scale (FSS) and modified fatigue impact scale (MFIS)
Study Visit 3:
Electromyography (EMG) and SFEMG (Single Fiber Electromyography) of the extensor digitorum
communis muscle (forearm muscle) will be performed on all women with fatigue and healthy
controls at the TTUHSC electrophysiology lab to evaluate for NMJ abnormalities. The mean
consecutive difference (MCD) of 20 pairs of single muscle fiber potentials will be collected
using SFEMG from each of the 20 women with multiple sclerosis and fatigue and will be
compared to MCD of 200 pair potentials from our recruited 10 normal control subjects and
also to the previously published normative data.
Inclusion Criteria:
Inclusion Criteria for MS Group (20 women)
1. Patients with relapsing remitting multiple sclerosis.
2. Age 18 to 65 years
3. Diagnosed with motor fatigue in multiple sclerosis > 6 weeks. Motor fatigue equates
to muscle fatigue due to physical exertion and is alleviated with rest and associated
with fatigability.
4. Has a fatigue severity scale score (FSS) of ≥5.
5. Ambulatory with Expanded Disability Status Scale score (EDSS) 1.5 -6.5.
Inclusion Criteria for Control Group (10 women)
1. Female with no history of multiple sclerosis and no complaint of fatigue
2. Age 18 to 65 years
Exclusion Criteria:
1. Patients with MS exacerbation or corticosteroid treatment within one month before the
study.
2. Patients with history or current diagnosis of:
- Untreated thyroid disease,
- Untreated vitamin D deficiency,
- pregnancy,
- taking over the counter energy booster in the last 1 week,
- taking medication that will improve the function of the neuromuscular junction
(i.e. pyridostigmine, steroid, rituximab, mycophenolate mofetil, azathioprine),
- myasthenia gravis,
- symptoms or history of polyneuropathy involving the upper extremities,
- myopathy,
- symptoms or history suggestive of C7, C 8 radiculopathy,
- motor neuron disease,
- polio,
- chronic inflammatory demyelinating polyneuropathy,
- Guillain-Barre syndrome,
- radial nerve palsy,
- sleep disorders (Epworth Sleepiness scale> 10 ), or
- significant depression ( Beck's Inventory of Depression Scale >17)
3. Taking major fatigue inducing medications. (e.g. Narcotics, and Sedatives)
4. Taking anticoagulation therapy. (e.g. warfarin and heparin)
We found this trial at
1
site
Click here to add this to my saved trials
